Parameter | Score |
---|---|
1. Scale | A |
2. Study Population | B |
3. Samples | B |
4. Measurand | A |
5. Pre-Analytical | C |
6. Replicate Analysis | B |
7. Steady State | C |
8. Outlier Analysis | B |
9. Normality | B |
10. Variance Homogeneity | C |
11. ANOVA | B |
12. CI | A |
13. No of Results | C |
14. Concentrations | A |
15. Total Score | C5,7,10,13 |
Comment |
Parameter | Score |
---|---|
Matrix | Serum |
Measurand | Creatinine |
Unit | umol / L |
Overall Analytical Principle Method | Unknown |
Number of Subjects | 16026 |
Number of Subjects included in BV estimation | 16026 |
Ethinicity | Caucasian |
Age Mean / Median | 40.0 |
Age Min | |
Age Max | |
Age SD | |
Number of Males | |
Number of Females | |
State of Well Being |
Healthy (excl pregnant)
|
Diseases | |
Study Duration Length | 84 |
Study Duration Units | Month |
Sampling Intervals, e.g. X sample(s) per Interval Unit | |
Interval Units | Week |
Sampling Times | Start Time:
End Time: |
Number of Samples | 1 |
Average Number of Samples Used for BV Estimation | 1.0 |
Average Number of Replicates | 1.0 |
Estimates of CVi | |
Calculated Confidence Intervals of CVi | Lower: , Upper: |
Estimates of CVg | 18.7 |
Calculated Confidence Intervals of CVg | Lower: 0.00, Upper: 0.00 |
Analytical CV | 1.0 |
Calculated Confidence Intervals of Analytical CV | Lower: 1.04, Upper: 1.04 |
Measurand Mean | 92.7 |
Measurand Min | |
Measurand Max | |
Measurand SD |